Montelukast Prescribing at NORTH HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,471
Total Quantity
63.9K
NHS Cost
£3.1K
vs National Avg
+260.9%
NORTH HOUSE SURGERY prescribed 2,471 items of Montelukast over the last 12 months at a cost of £3,054 to the NHS. This is 260.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
217
Jul 2026
191
Jul 2026
227
Jul 2026
206
Jul 2026
203
Jul 2026
208
Jul 2026
212
Jul 2026
204
Jul 2026
213
Jul 2026
198
Jul 2026
186
Jul 2026
206
Prescribing Details
| Total Items | 2,471 |
|---|---|
| Total Quantity | 63,868 |
| Total NHS Cost | £3,054 |
| Presentations | 4 different forms |
| vs National Average | +260.9% |
Montelukast Prescribing Comparison
| This practice | 2,471 items |
|---|---|
| National average per practice | 685 items |
| Difference | +260.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.